Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck

References

• AngKKBerkeyBATuXImpact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinomaCancer Res2002627350612499279
   PubMed Web of Science ®Google Scholar
• AngKKAndratschkeNHMilasLEpidermal growth factor receptor and response of head and neck carcinoma to therapyInt J Radiat Oncol Biol Phys2004589596514967456
   PubMed Web of Science ®Google Scholar
• BaselgaJPfisterDCooperMRPhase I studies of antiepidermal Growth factor receptor chimeric antibody C225 alone and in combination with cisplatinJ Clin Oncol2000189041410673534
   PubMed Web of Science ®Google Scholar
• BaselgaJTrigoJMBourhisJPhase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck cancerJ Clin Oncol20052355687716009950
   PubMed Web of Science ®Google Scholar
• BonnerJAHarariPMGiraltJRadiotherapy plus cetuximab for squamous cell carcinoma of the head and neckN Engl J Med20063545677816467544
   PubMed Web of Science ®Google Scholar
• BourhisJRiveraFMesniaRPhase I/II study of cetuximab in combination with cisplatin or carboplatin and fluorouracil in patients with recurrent of metastatic squamous cell carcinoma of the head and neckJ Clin Oncol20062428667216717293
   PubMed Web of Science ®Google Scholar
• BurtnessBGoldwasserMAFloodVPhase III randomized trials of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an eastern cooperative oncology group studyJ Clin Oncol20052386465416314626
   PubMed Web of Science ®Google Scholar
• CarpenterGCohenSEpidermal growth factorJ Biol Chem19902657709122186024
   PubMed Web of Science ®Google Scholar
• CohenEEWLingenMWVokesEEThe expanding role of systemic therapy in head and neck cancerJ Clin Oncol20042217435215117998
   PubMed Web of Science ®Google Scholar
• ConstenlaDOHillMEA’HernRPChemotherapy for symptom control in recurrent squamous cell carcinoma of the head and neckAnn Oncol1997844599233523
   PubMed Web of Science ®Google Scholar
• DassonvilleOFormentoJLFrancoualMExpression of epidermal growth factor receptor and survival in upper aerodigestive tract cancerJ Clin Oncol199311187388410112
   PubMed Web of Science ®Google Scholar
• EriksenJGSteinicheTAskaaJThe prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinoma of the head and neckInt J Radiat Oncol Biol Phys200458561614751528
   PubMed Web of Science ®Google Scholar
• FanZLuYWuXAntibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cellsJ Biol Chem1994269275956027961676
   PubMed Web of Science ®Google Scholar
• ForastiereAMetchBSchullerDERandomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous cell carcinoma of the head and neck: a Southwest Oncology Group studyJ Clin Oncol1992101245511634913
   PubMed Web of Science ®Google Scholar
• GillGNKawamotoTCochetCMonoclonal anti-epidermal Growth factor receptor antibodies wich are inhibitors of epidermal growth factor binding and antagonist of epidermal growth factor-stimulated tyrosine protein kinase activityJ Biol Chem19842597755606330079
   PubMed Web of Science ®Google Scholar
• GoldsteinNIPrewettMZuklysKBiological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft modelClin Cancer Res19951131189815926
   PubMed Web of Science ®Google Scholar
• GrandisRJMelhemMFGoodingWELevels of TGF alpha and EGFR protein in head and neck squamous cell carcinoma and patients survivalJ Natl Cancer Inst199890824329625170
   PubMed Web of Science ®Google Scholar
• GuptaAKMcKennaWGWeberCNLocal recurrence in head and neck cancer: relationship to radiation resistance and signal transductionClin Cancer Res200288859211895923
   PubMed Web of Science ®Google Scholar
• HarariPMHuangSMHead and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiationInt J Radiat Oncol Biol Phys2001494273311173137
   PubMed Web of Science ®Google Scholar
• HarariPMHuangSRadiation combined with EGFR signal inhibitors: head and neck cancer focusSemin Radiat Oncol200616384416378905
   PubMed Web of Science ®Google Scholar
• HerbstRSShinDMMonoclonal antibodies to target epidermal growth factor receptor- positive tumors: a new paradigm for cancer therapyCancer2002941593161111920518
   PubMed Web of Science ®Google Scholar
• HerbstRSArquetteMShinMDPhase II multicenter study of the epidermal growth receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neckJ Clin Oncol20052355788716009949
   PubMed Web of Science ®Google Scholar
• HuangSMBockJMHarariPMEpidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis and radiosensivity in squamous cell carcinoma of the head and neckCancer Res19995919354010213503
   PubMed Web of Science ®Google Scholar
• HuangSHarariPMModulation of radiation response following EGFR blockade in squamous cell carcinoma: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesisClin Cancer Res2000621667410873065
   PubMed Web of Science ®Google Scholar
• HynesNELaneHAERBB Receptors and cancer: the complexity of targeted inhibitorsNat Rev Cancer200553415415864276
   PubMed Web of Science ®Google Scholar
• LeonXHittRConstenlaMA retrospective analysis of the outcome of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck refractory to a platinum-based chemotherapyClin Oncol20051741824
   PubMed Web of Science ®Google Scholar
• MendelsohnJBaselgaJStatus of epidermal growth factor receptor antagonists in the biology and treatment of cancerJ Clin Oncol20032127879912860957
   PubMed Web of Science ®Google Scholar
• MerlanoMMarchettiGRadiochemotherapy in head and neck cancerCancer Treat Rev200329291612927569
   PubMed Web of Science ®Google Scholar
• MerlanoMColantonioINumicoGAlternating radiotherapy and chemotherapy plus cetuximab in advanced head and neck cancer (HNC): the AlteRCC Phase I-II trialsAnn Oncol2005167 abstr B20
   Google Scholar
• MerlanoMAlternating chemotherapy and radiotherapy in locally advanced head and neck cancer An alternative?The Oncologist20061114615116476835
   PubMed Web of Science ®Google Scholar
• NicholsonRIGeeGMHarperMEEGFR and cancer prognosisEur J Cancer200137S9S15 suppl 411597399
   PubMed Web of Science ®Google Scholar
• O-CharoenratPRhys-EvansPHArcherDJC-erbB receptors in squamous cell carcinoma of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factorsOral Oncol200238738011755824
   PubMed Web of Science ®Google Scholar
• OlayioyeMNeveRLaneHThe ErbB2 signaling network: Receptor heterodimerization in development and cancerEMBO J20001931596710880430
   PubMed Web of Science ®Google Scholar
• PfisterDGSuBYKrausDHConcurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigmJ Clin Oncol20062410727816505426
   PubMed Web of Science ®Google Scholar
• RobertFEzekielMPSpencerSAPhase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancerJ Clin Oncol20011932344311432891
   PubMed Web of Science ®Google Scholar
• SantiniJFormentoJLFrancoualMCharacterization, quantification and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomaHead Neck19911313292022478
   PubMed Web of Science ®Google Scholar
• SaltzLKiesMAbruzzeseJThe presence and intensity of the cetuximab-induced acne like rash predicts increased survival in studies accross multiple malignanciesProc Am Soc Clin Oncol200322204a abstr 817
   Web of Science ®Google Scholar
• SatoJDKawamotoTLeADBiological effect in vitro of monoclonal antibodies to human EGF receptorsMol Biol Med19831511296094961
   PubMedGoogle Scholar
• SchlessingerJThe epidermal growth factor receptor as a multifunctional allosteric proteinBiochemistry1988273119233291943
   PubMed Web of Science ®Google Scholar
• SchleissingerJCell signaling by receptor tyrosine kinasesCell20001032112511057895
   PubMed Web of Science ®Google Scholar
• StellPMMortonRPCampbellITSurvival after palliative cytotoxic chemotherapy for head and neck cancerLancet1983212056196584
   PubMed Web of Science ®Google Scholar
• ThomsonDMGillGNThe EGF receptor: Structure, regulation and potential role in the malignancyCancer Surv198547677882824044
   PubMedGoogle Scholar
• TrigoJHittRKoralewskiPCetuximab monotherapy is active in patients with platinum refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN): Results of a phase II studyJ Clin Oncol200422488s abstr 5502
   Google Scholar
• UlrichASchlessingerJSignal trasduction by receptors with tyrosine kinase activityCell199061203122158859
   PubMed Web of Science ®Google Scholar
• YardenYSliwkowskiMUntangling the ErbB signaling networkNat Rev Mol Cell Bio200121273711252954
   PubMed Web of Science ®Google Scholar